Active Government Funding Opportunities

This DoD program funds innovative research into tuberous sclerosis complex (TSC) to drive critical discoveries and improve patient care. It welcomes both established researchers and investigators new to the TSC field, with separate competitive tracks.

This DoD grant funds exploratory research into tuberous sclerosis complex treatments, welcoming high-risk, innovative concepts without requiring preliminary data. It supports early-stage hypothesis development to advance breakthrough therapeutic approaches.

This Army Medical Research Acquisition Activity award supports mentored clinical research in vision-related medical challenges. It aims to develop clinical solutions and advance vision care capabilities through structured mentorship and research training.

This DoD award funds multidisciplinary, multi-institutional consortia addressing transformative breast cancer research challenges. Led by up to five PIs and consumer advocates, projects must tackle major problems requiring collaborative breakthroughs that single investigators cannot achieve.

Army seeks investigator-initiated research proposals addressing vision science and ocular performance challenges. Support ranges from basic science through applied research to advance soldier visual capabilities and medical treatments.

Develop ALS therapeutics from preclinical validation through FDA IND-enabling studies. This award accelerates drug candidates toward clinical testing while requiring parallel development of mechanism-specific biomarkers for improved patient selection and trial design.

Develop and test broadly applicable clinical technologies addressing urgent military health needs through translational research and early-phase clinical trials. Multi-PI teams will advance platform products that benefit Service Members, Veterans, and their families.

This DoD funding supports translational lung cancer research converting promising discoveries into clinical applications. Applicants can pursue advanced preclinical studies or pilot clinical trials addressing priority research areas.

The Army seeks translational research advancing vision science and optical technologies for military applications. This opportunity funds development of novel vision-related capabilities to bridge fundamental research and field-deployable solutions.

Support clinical trials evaluating new treatments, devices, and approaches for autism management. Awards fund proof-of-concept through large-scale efficacy studies, with funding incentives for early-career researchers partnering with experienced mentors.

Supports early-stage, high-risk lung cancer research with potential for breakthrough discoveries. Designed for conceptually innovative projects, including a dedicated track for new faculty investigators seeking transformative advances.

This grant program funds digital equity initiatives for Indian Tribes, Alaska Native entities, and Native Hawaiian organizations. It supports capacity building and competitive projects to expand broadband access and digital skills in underserved Native communities.

This award supports health services research addressing traumatic brain injury and psychological health outcomes in military populations. It seeks evidence-based studies to improve clinical care delivery and patient outcomes for service members.

Fundamental medical research addressing congressionally prioritized disease areas. Supports use-inspired basic research with preliminary data to advance patient care and quality of life outcomes.

Support public diplomacy programming at American Spaces in Zambia through the Zambia-US Exchanges Alumni Association. Fund cultural, educational, and professional development activities promoting U.S.-Zambian understanding and Freedom 250 anniversary initiatives.

This DoD funding supports patient-centered research to improve lung cancer outcomes and survivorship experiences. Projects must include patient/survivor advocates and can pursue translational or clinical research, including pilot trials.

The Army seeks collaborative melanoma research teams to advance understanding and treatment of melanoma through innovative scientific approaches. This team science award supports competitive research that addresses critical gaps in melanoma biology and clinical outcomes.

This award supports clinical trials investigating health outcomes and treatments for service members exposed to toxic substances during military operations. The research aims to establish evidence-based interventions and improve medical care for affected veterans.

Support for established neurofibromatosis researchers to lead a multi-institutional virtual academy mentoring early-career investigators. The program combines pilot research projects with structured mentorship to advance NF science and develop the next generation of research leaders.

Develop novel therapeutics and diagnostic tools to prevent, treat, or detect tick-borne diseases like Lyme disease. This program funds R&D to address a significant public health threat through innovative medical countermeasures.

The Army seeks clinical trial research to advance traumatic brain injury and psychological health treatments for service members. This funding supports evidence-based interventions to improve diagnosis, prevention, and recovery outcomes.

DoD seeks development of a multiomic atlas from human bone marrow failure samples to create an open-access research resource. This dataset will enable discoveries advancing understanding of bone marrow failure diseases across the research and clinical community.

NSF FINDERS FOUNDRY supports K-12 educators, technologists, and researchers collaborating to develop AI-integrated learning solutions and tools. Teams co-design evidence-based technologies addressing real challenges identified by students and educators to prepare the workforce for an AI-driven future.

This DoD funding supports innovative research to transform Alzheimer's diagnosis and disease monitoring. Projects must demonstrate non-incremental solutions that overcome barriers to diagnosis and prognosis, with preliminary data and community collaboration required.

Accelerate cancer treatment breakthroughs through clinical trials testing new drugs, devices, and emerging therapies. This award funds rapid-cycle trials from proof-of-concept to phase III, addressing the urgent need to translate promising cancer interventions into patient care.